IBRX
ImmunityBio, Inc. Common StockData: 2026-09-11
Quick Stats
Sep 11, 202639.5
AI Score
SELL1.51
Volume Ratio
Nov 03, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
IBRX Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
IBRX Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
IBRX Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IBRX Daily Out of Money Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IBRX Daily In the Money Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IBRX Most Active Options by Volume(near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IBRX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
IBRX Stock Summary
Last updated Sep 11, 2026
IBRX is currently trading at $7.91, positioned above its 200-day moving average of $6.72, indicating a long-term uptrend. The stock has a 52-week range of $1.95 to $12.43.
Technical Analysis: The 50-day moving average stands at $7.82, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 50.365, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.067, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates IBRX at 39.5/100 with a SELL recommendation.
IBRX (ImmunityBio, Inc. Common Stock) Indicators
Last updated Sep 11, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 50.365 |
| CMF (20) | 0.067 |
| ROC (10) | -5.833 |
| ADX (14) | 22.46 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.093 |
| AROONOSC (14) | 21.429 |
| WILLAMS %R (14) | -65.385 |
| MFI (14) | 61.569 |
IBRX Candlestick Patterns
Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.
| Date | Pattern | Signal | 5-Day Hit Rate | Edge vs Baseline | Sample |
|---|---|---|---|---|---|
| Sep 10 | Three Inside Down (contrarian — textbook says the opposite) | Bullish | 56.9% | +3.9 pts | 8868 |
| Aug 31 | On-Neck | Bearish | 49.1% | +2.1 pts | 3813 |
These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.
ImmunityBio, Inc. Common Stock is above both the 50 Day and 200 Day SMA which is considered Bullish.
IBRX Moving Averages Analysis
ImmunityBio, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Sep 11, 2026
ImmunityBio, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Sep 11, 2026
IBRX (ImmunityBio, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Sep 11, 2026
| Days | MA |
|---|---|
| 10 | 8.01 |
| 20 | 7.97 |
| 30 | 7.78 |
| 50 | 7.82 |
| 100 | 7.73 |
| 200 | 6.72 |
IBRX Fundamental Analysis
| P/E (Forward) | 114.9425 |
| P/E (Trailing) | -- |
| Market Cap ($) | 8.2 billion |
| Earnings/Share ($) | -0.91 |
| Net Profit Margin (%) | -- |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.915 |
| EPS Estimate Next Year ($) | -0.1267 |
| WallStreet Target Price ($) | 12.75 |
| Most Recent Quarter |
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.